Gout Clinical Trial - To Evaluate Drug Interactions Between XNW3009,

See also
Status	Clinical Trial	Phase
Completed	`NCT04060173` - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671	Phase 1
Not yet recruiting	`NCT06187519` - UR+AIMS Gout Wearable Skin Uric Acid Monitor Study	N/A
Completed	`NCT03635957` - Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout	Phase 4
Completed	`NCT04966325` - Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects	Early Phase 1
Completed	`NCT03015948` - A Single Dose Study of SHR4640 in Healthy Male Volunteers	Phase 1
Completed	`NCT02855437` - Novel Methods for Ascertainment of Gout Flares -A Pilot Study	N/A
Active, not recruiting	`NCT02702375` - Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases	N/A
Completed	`NCT01407874` - A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency	Phase 2
Completed	`NCT00995618` - Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia	Phase 2
Completed	`NCT00985127` - Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout	Phase 2
Terminated	`NCT04987294` - Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease	Phase 2
Completed	`NCT03291782` - D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers	Phase 1
Recruiting	`NCT03388515` - A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects.	Phase 1
Completed	`NCT06189404` - Effect of Tigulixostat on the Pharmacokinetics of Theophylline	Phase 1
Enrolling by invitation	`NCT03336203` - The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF)	Phase 4
Recruiting	`NCT05586958` - Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients	Phase 3
Recruiting	`NCT04047394` - A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunteers	Phase 1
Not yet recruiting	`NCT05507723` - Tight Control of Gouty Arthritis Compared to Usual Care	N/A
Recruiting	`NCT06056570` - Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia	Phase 1/Phase 2
Completed	`NCT02557126` - Study of URC102 to Assess the Safety and Efficacy in Gout Patients	Phase 2

NCT number	NCT05324423
Study type	Interventional
Source	The Affiliated Hospital of Qingdao University
Contact	Yu Cao, Doctor
Phone	18661809090
Email	caoyu1767@126.com
Status	Recruiting
Phase	Phase 1
Start date	October 18, 2021
Completion date	September 1, 2022

To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms